| 產品名稱 |
Microsporum canis Bodin |
| 商品貨號 |
B230653 |
| Deposited As |
Microsporum canis Bodin, anamorph |
| Strain Designations |
831 |
| Application |
Biomedical Research and Development Material |
| Biosafety Level |
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format |
frozen |
| Storage Conditions |
Frozen: -80°C or colder
Freeze-Dried: 2°C to 8°C
Live Culture: See Propagation Section |
| Type Strain |
no |
| Preceptrol® |
no |
| Comments |
Produces abundant microconidia |
| Medium |
ATCC® Medium 28: Emmons' modification of Sabouraud's agar
|
| Growth Conditions |
Temperature: 30.0°C |
| Name of Depositor |
M Baxter |
| Special Collection |
NCRR Contract |
| Chain of Custody |
ATCC <<--M Baxter<<--M.F. Simpanya |
| Isolation |
human infected with cat ringworm, New Zealand |
| References |
Simpanya MF, Baxter M. Partial characterization of proteolytic enzymes of Microsporum canis and Microsporum cookei. Mycoses 39: 279-282, 1996. PubMed: 9009645
Michael Baxter, personal communication
|
